Beste apotheek van Nederland

O'Sullivan J D. Apomorphine as an alternative to sildenafil in
Parkinson's disease. [References]. Journal of Neurology,
Neurosurgery & Psychiatry 2002;72(5):681
Oefelein M G. Time to normalization of serum testosterone after
3-month luteinizing hormone-releasing hormone agonist
administered in the neoadjuvant setting: implications for dosing
schedule and neoadjuvant study consideration.[see comment].
Br J Urol 1998;160(5):1685-1688.
Ojumu A, Dobs A S. Is Hypogonadism a Risk Factor for Sexual
Dysfunction?. J Androl 2003;24(6 SUPPL.):S46-S51.
Onu P E. Depot medroxyprogesterone in the management of
benign prostatic hyperplasia. Eur Urol 1995;28(3):229-235.
Opsomer R J, Wese F X, De Groote P et al. The external
vacuum device in the management of erectile dysfunction. Acta
Urol Belg 1997;65(4):13-16.
Osterloh I H, Riley A. Clinical update on sildenafil citrate.
[Review] [58 refs]. Br J Clin Pharmacol 2002;53(3):219-223.
Owens J. Seeking selectivity. Nat Rev Genet 2005;4(2):106
Ozbek E, Yurekli M, Soylu A et al. The role of adrenomedullin
in varicocele and impotence. BJU Int 2000;86(6):694-698.
Ozdel O, Oguzhanoglu A, Oguzhanoglu N K et al. A follow-up
study of male sexual disorders: The neurophysiological
assessments, anxiety-depression levels, and response to
fluoxetine treatment [10]. J Clin Psychopharmacol
2004;24(4):461-463.
Paice Judith A, Penn Richard D, Ryan Will G. Altered sexual
function and decreased testosterone in patients receiving
intraspinal opioids. J Pain Symptom Manage 1994;9(2):126-131.
Paick J S, Yang J H, Kim S W et al. Severity of erectile
dysfunction in married impotent patients: interrelationship with
anthropometry, hormones, metabolic profiles and lifestyle. Int J
Urol 2007;14(1):48-53.
Paick J S, Yang J H, Kim S W et al. The role of prolactin levels
in the sexual activity of married men with erectile dysfunction.
BJU Int 2006;98(6):1269-1273.
Paick S H, Meehan A, Lee M et al. The relationship among
lower urinary tract symptoms, prostate specific antigen and
erectile dysfunction in men with benign prostatic hyperplasia:
results from the proscar long-term efficacy and safety study. Br
J Urol 2005;173(3):903-907.
Palha A P, Gomes F A, Martins A S et al. [Clinical,
multicentric, and open study to evaluate the efficacy of and
tolerance to sildenafil in patients with erectile dysfunction]. Acta
Med Port. 2002;15(4):249-256.
Pan C C, Lin J S N, Wong W S. Comparison of effect on
erection between vacuum constriction devices and intra-
cavernous injection of prostaglandin E1. Asian J Surg
1997;20(2):162-166.
Papatsoris A G, Deliveliotis C, Singer C et al. Erectile
dysfunction in Parkinson's disease. Urology
2006;67(3):447-451.
Parazzini F, Menchini Fabris F, Bortolotti A et al.
Frequency and determinants of erectile dysfunction in
Italy. Eur Urol 2000;37(1):43-49.
Paris G, Sponsel W E, Sandoval S S et al. Sildenafil
increases ocular perfusion. Int Ophthalmol 2001;23(4­
6):355-358.
Parker C. The Scandinavian Prostate Cancer Group
Study: The case for conservative management. BJU
Int 2005;96(7):952-953.
Parsons J K, Marschke P, Maples P et al. Effect of
methylprednisolone on return of sexual function after
nerve-sparing radical retropubic prostatectomy.
Urology 2004;64(5):987-990.
Patankar M. Sildenafil citrate. J Indian Med Assoc
2000;98(12):
Patterson D, Kloner R, Effron M et al. The effect of
tadalafil on the time to exercise-induced myocardial
ischaemia in subjects with coronary artery disease. Br
J Clin Pharmacol 2005;60(5):459-468.
Pegge N C, Twomey A M, Vaughton K et al. The role
of endothelial dysfunction in the pathophysiology of
erectile dysfunction in diabetes and in determining
response to treatment. Diabet Med 2006;23(8):873­
878.
Penson D F, Feng Z, Kuniyuki A et al. General quality
of life 2 years following treatment for prostate cancer:
what influences outcomes? Results from the prostate
cancer outcomes study.[see comment]. Am J Clin
Oncol 2003;21(6):1147-1154.
Perez Martin A, Skinner Eila C, Meyerowitz Beth E E.
Sexuality and intimacy following radical
prostatectomy: Patient and partner perspectives.
[References]. Health Psychol 2002;21(3):288-293.
Perimenis P, Athanasopoulos A, Papathanasopoulos P
et al. Gabapentin in the management of the recurrent,
refractory, idiopathic priapism. Int J Impot Res
2004;16(1):84-85.
Pescatori E S, Calpista A, Artibani W et al. Selfinjection
devices for intracavernosal pharmacotherapy:
operational classification and safety considerations. Int
J Impot Res 1996;8(2):53-57.
Pescatori E S, Silingardi V, Galeazzi G M et al.
Audiovisual sexual stimulation by virtual glasses is
effective in inducing complete cavernosal smooth
muscle relaxation: a pharmacocavernosometric study.
Int J Impot Res 2000;12(2):83-88.
D-204